Erturk, I. Et Al. 2018. Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin. International Journal of Medical Science and Clinical Invention , vol.5, no.11 , 4157-4161.

Erturk, I., , Ozgurtas, a., Elasan, S., Acar, R., Buyukturan, G., ... Aydin, F. N.(2018). Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin. International Journal of Medical Science and Clinical Invention , vol.5, no.11, 4157-4161.

Erturk, Ismail Et Al. "Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin," International Journal of Medical Science and Clinical Invention , vol.5, no.11, 4157-4161, 2018

Erturk, Ismail Et Al. "Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin." International Journal of Medical Science and Clinical Invention , vol.5, no.11, pp.4157-4161, 2018

Erturk, I. Et Al. (2018) . "Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin." International Journal of Medical Science and Clinical Invention , vol.5, no.11, pp.4157-4161.

@article{article, author={Ismail Erturk Et Al. }, title={Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin}, journal={International Journal of Medical Science and Clinical Invention}, year=2018, pages={4157-4161} }